InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-31.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Explore the detailed record of transactions filed by Sendrow Jerrold, Director. Director active across 1 company, notably Virpax Pharmaceuticals, Inc.. In total, 2 reports have been logged. Split: 2 buys · 0 sell. Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Sendrow Jerrold
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
4,500 shares@ €1.201528.5% of flowCommon Stock, $0.00001 par valueSEC:0001493152-22-015224:0
Canonical exit: 22 Aug 2022 (T+90)
3,900 shares@ €3.480971.5% of flowCommon Stock, $0.00001 par valueSEC:0000905718-21-001536:0
Canonical exit: 20 Feb 2022 (T+90)
2 of 2 declarations
About Sendrow Jerrold
Jerrold Sendrow is a Director at Virpax Pharmaceuticals, Inc. In this role, he contributes to the governance of the company and strategic decision-making. Virpax Pharmaceuticals focuses on developing innovative treatments for serious diseases. Jerrold's experience in the pharmaceutical sector is valuable in guiding the company's direction.
